The biological role of HGF-MET axis in tumor growth and development of metastasis

被引：85
|
作者：
Lesko, Ewa [1 ]
Majka, Marcin [1 ]
机构：
[1] Jagiellonian Univ, Dept Transplantat, Polish Amer Inst Pediat, Sch Med, Krakow, Poland
来源：
FRONTIERS IN BIOSCIENCE-LANDMARK | 2008年 / 13卷
关键词：
cancer; tumor; neoplasia; hepatocyte growth factor; HGF-MET; metastasis; review;
D O I：
10.2741/2760
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Hepatocyte growth factor (HGF) and its receptor MET play an important role in cancer growth and metastasis. Activation of MET elicit multiple cellular responses regulating cell survival, morphogenesis, adhesion, migration, breakdown of extracellular matrix (ECM) and angiogenesis. Numerous disorders related to deregulation of HGF-MET axis have been reported. Thus, new therapeutic agents targeting HGF-MET signaling have been sought. Here, we will present data describing the role of HGF-MET axis in growth and metastasis of tumor cells together with the recent approaches to block this axis.
引用
收藏
页码：1271 / 1280
页数：10
相关论文
共 50 条
  • [1] The HGF-Met Signaling Axis: Emerging Themes and Targets of Inhibition
    Steffan, Joshua J.
    Coleman, David T.
    Cardelli, James A.
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2011, 12 (01) : 12 - 22
  • [2] HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation
    Spina, Anna
    De Pasquale, Valeria
    Cerulo, Giuliana
    Cocchiaro, Pasquale
    Della Morte, Rossella
    Avallone, Luigi
    Pavone, Luigi Michele
    BIOMEDICINES, 2015, 3 (01): : 71 - 88
  • [3] The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance
    Huang, Xing
    Gan, Guangming
    Wang, Xiaoxiao
    Xu, Ting
    Xie, Wei
    AUTOPHAGY, 2019, 15 (07) : 1258 - 1279
  • [4] The role of the HGF/Met axis in mesothelioma
    Thayaparan, Thivyan
    Spicer, James F.
    Maher, John
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 363 - 370
  • [5] The activation of GSK3 by HGF-MET axis is responsible for differentiation of rhabdomyosarcoma cells
    Miekus, Katarzyna
    Bobela, Wojciech
    Majka, Marcin
    CANCER RESEARCH, 2011, 71
  • [6] Role of HGF-MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer
    Della Corte, Carminia Maria
    Fasano, Morena
    Papaccio, Federica
    Ciardiello, Fortunato
    Morgillo, Floriana
    BIOMEDICINES, 2014, 2 (04): : 345 - 358
  • [7] Tumor-stroma interactions reduce the efficacy of adenoviral therapy through the HGF-MET pathway
    Yasui, Takaharu
    Ohuchida, Kenoki
    Zhao, Ming
    Onimaru, Manabu
    Egami, Takuya
    Fujita, Hayato
    Ohtsuka, Takao
    Mizumoto, Kazuhiro
    Tanaka, Masao
    CANCER SCIENCE, 2011, 102 (02): : 484 - 491
  • [8] Tumor-stroma interactions reduce the efficacy of adenoviral therapy through the HGF-MET pathway
    Zhao, Ming
    Yasui, Takaharu
    Ohuchida, Kenoki
    Cui, Lin
    Onimaru, Manabu
    Egami, Takuya
    Fujita, Hayato
    Ohtsuka, Takao
    Mizumoto, Kazuhiro
    Tanaka, Masao
    JOURNAL OF GENE MEDICINE, 2014, 16 (7-8): : 265 - 266
  • [9] MACC1, a newly identified regulator of HGF-MET signaling, predicts metastasis in colorectal cancer
    Stein, U.
    Arlt, F.
    Schwabe, H.
    Walther, W.
    Smith, J.
    Sack, U.
    Fichtner, I
    Birchmeier, W.
    Schlag, P. M.
    ONKOLOGIE, 2010, 33 : 213 - 214
  • [10] A novel HGF-MET paracrine signaling pathway promotes growth and resistance to chemotherapy in lung cancer
    Choi, Hyejin
    Gao, Ding Cheng
    Lee, Sharrell B.
    Durrans, Anna
    Ryu, Seongho
    Elemento, Olivier
    Wong, Stephen
    Altorki, Nasser K.
    Mittal, Vivek
    CANCER RESEARCH, 2014, 74 (19)
12345